| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marcin Siwek, Adrian Andrzej Chrobak, Aleksandra Gorostowicz, Patrycja Król, Dominika Dude. Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review. Frontiers in pharmacology. vol 14. 2024-01-19. PMID:38239199. |
the aim of our study was to evaluate the efficacy of cariprazine augmentation of clozapine in treatment-resistant schizophrenia in a retrospective chart review. |
2024-01-19 |
2024-01-21 |
Not clear |
| Marcin Siwek, Adrian Andrzej Chrobak, Aleksandra Gorostowicz, Patrycja Król, Dominika Dude. Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review. Frontiers in pharmacology. vol 14. 2024-01-19. PMID:38239199. |
our study presents a thorough clinical description of the largest number of treatment-resistant schizophrenia patients medicated using cariprazine augmentation of clozapine in a "real-world" setting. |
2024-01-19 |
2024-01-21 |
Not clear |
| Roshan Poudel, Barron Lerne. The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine. Harvard review of psychiatry. vol 32. issue 1. 2024-01-05. PMID:38181102. |
anecdotal evidence of superior efficacy and lack of extrapyramidal symptoms in treating schizophrenia made clozapine a promising therapy in the united states during the early 1970s. |
2024-01-05 |
2024-01-08 |
Not clear |
| Floor C E Groenewald, Rob M Ko. Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults. International journal of geriatric psychiatry. vol 39. issue 1. 2024-01-05. PMID:38180349. |
side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults. |
2024-01-05 |
2024-01-07 |
Not clear |
| Floor C E Groenewald, Rob M Ko. Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults. International journal of geriatric psychiatry. vol 39. issue 1. 2024-01-05. PMID:38180349. |
to study the differences in side effects of clozapine between older adults aged ≥55 years and younger adults aged 18-55 years with treatment-resistant schizophrenia. |
2024-01-05 |
2024-01-07 |
Not clear |
| Kilian Lommer, Franziska Tutzer, Alex Hofe. Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient. International clinical psychopharmacology. 2024-01-03. PMID:38170806. |
we report the case of a 49-year-old male treatment-resistant schizophrenia patient, whose treatment with clozapine and sertraline was supplemented with cariprazine 1.5 mg/day while regularly presenting for electroconvulsive therapy. |
2024-01-03 |
2024-01-06 |
Not clear |
| Aslihan Aksar, Justina Lutz, Elias Wagner, Wolfgang Strube, Jurjen J Luykx, Alkomiet Hasa. Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. European archives of psychiatry and clinical neuroscience. 2024-01-02. PMID:38165458. |
among the original articles, two studies provided data on the association between clozapine use and antibody responses to vaccination, both indicating that clozapine use in schizophrenia may be associated with reduced levels of immunoglobulins. |
2024-01-02 |
2024-01-05 |
Not clear |
| Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonse. Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-12-22. PMID:38135678. |
non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: the clinicians' perspectives. |
2023-12-22 |
2023-12-25 |
Not clear |
| Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonse. Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-12-22. PMID:38135678. |
clozapine is the gold standard for treating treatment-resistant schizophrenia although continuously underutilized. |
2023-12-22 |
2023-12-25 |
Not clear |
| Jing Ding, Jianfeng Liu, Yan Zhang, Huan Xing, Yang Zhang, Luyao Li, Suo Zhang, Huiyuan Wang, Liu Yang, Xiaohua Cu. A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019-2022. Asian journal of psychiatry. vol 91. 2023-12-19. PMID:38113699. |
a retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: data from the therapeutic drug monitoring service, 2019-2022. |
2023-12-19 |
2023-12-23 |
Not clear |
| Ellen Kingston, Malcolm Tingle, Brandi L Bellissima, Nuala Helsby, Kathryn Burn. CYP-catalysed Cycling of Clozapine and Clozapine- Xenobiotica; the fate of foreign compounds in biological systems. 2023-12-18. PMID:38108307. |
cyp-catalysed cycling of clozapine and clozapine- clozapine is an effective atypical antipsychotic indicated for treatment-resistant schizophrenia but is under-prescribed due to the risk of severe adverse drug reactions such as myocarditis. |
2023-12-18 |
2023-12-21 |
Not clear |
| Fatemeh Mohammad-Gholizad, Iman Karimzadeh, Ebrahim Moghimi-Sarani, Mahdi Arshadi, Negar Mortazav. Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial. Journal of clinical psychopharmacology. vol 44. issue 1. 2023-12-15. PMID:38100776. |
clozapine, a second-generation antipsychotic medication, is mainly indicated for managing treatment-resistant schizophrenia. |
2023-12-15 |
2023-12-18 |
Not clear |
| Liang Lv, Ping Guo, Min Feng, Yu Fang, Shi-Kai Wang, Huan-Xin Che. Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report. World journal of clinical cases. vol 11. issue 32. 2023-12-11. PMID:38073685. |
we successfully treated a chronic schizophrenia patient with comorbid long-term severe td using deutetrabenazine, clozapine, and mect. |
2023-12-11 |
2023-12-17 |
Not clear |
| Xenia A K Kersting, Nicoletta Momtahen, Klaus Lie. Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations. Case reports in psychiatry. vol 2023. 2023-12-07. PMID:38058314. |
this paper reports the case of a 27-year-old man with paranoid schizophrenia who was finally stabilized on clozapine medication. |
2023-12-07 |
2023-12-10 |
Not clear |
| Andrea Amerio, Luca Magnani, Gabriele Arduino, Fabio Fesce, Renato de Filippis, Alberto Parise, Alessandra Costanza, Khoa D Nguyen, Daniele Saverino, Domenico De Berardis, Andrea Aguglia, Andrea Escelsior, Gianluca Serafini, Pasquale De Fazio, Mario Amor. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia. Current neuropharmacology. 2023-12-04. PMID:38031778. |
immunomodulatory effects of clozapine: more than just a side effect in schizophrenia. |
2023-12-04 |
2023-12-10 |
Not clear |
| Tomihisa Niitsu, Norio Yasui-Furukori, Ken Inada, Tetsufumi Kanazawa, Masaomi Iyo, Takefumi Ueno, Ryota Hashimot. Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey. Schizophrenia research. 2023-12-01. PMID:38038428. |
clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia. |
2023-12-01 |
2023-12-10 |
Not clear |
| Nadine Halawa, Mackenzie Armstrong, Sarah Fancy, Sabina Abid. Clozapine-induced myocarditis and subsequent rechallenge: a narrative literature review and case report. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 32. issue 4. 2023-11-30. PMID:38034406. |
clozapine is an antipsychotic medication that has been proven effective for the management of treatment-resistant schizophrenia (trs). |
2023-11-30 |
2023-12-10 |
Not clear |
| Nisha Chandrakant Bhavsar, Julie Ann Dopheide, Timothy Eugene Botello, Mengxi Wan. Therapeutic Drug Level Monitoring of Antipsychotics at an Inpatient Psychiatric Hospital. Therapeutic drug monitoring. 2023-11-29. PMID:38018824. |
the american psychiatric association guidelines for the treatment of patients with schizophrenia state that the utility of antipsychotic therapeutic drug monitoring (tdm) remains unclear, except for clozapine or assessing adherence. |
2023-11-29 |
2023-12-07 |
Not clear |
| Yuki Kikuchi, Yuji Yada, Yuji Otsuka, Fumiaki Ito, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomit. Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-11-24. PMID:37985654. |
slower clozapine titration is associated with delayed onset of clozapine-induced fever among japanese patients with schizophrenia. |
2023-11-24 |
2023-11-28 |
Not clear |
| Yuki Kikuchi, Yuji Yada, Yuji Otsuka, Fumiaki Ito, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomit. Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-11-24. PMID:37985654. |
we retrospectively analyzed the correlation between clozapine titration rate and fever onset date in 254 japanese patients, including 55 with treatment-resistant schizophrenia who developed clozapine-induced fever. |
2023-11-24 |
2023-11-28 |
Not clear |